These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 8738209)

  • 1. Predicted ligand interactions of 3'5'-cyclic nucleotide-gated channel binding sites: comparison of retina and olfactory binding site models.
    Scott SP; Harrison RW; Weber IT; Tanaka JC
    Protein Eng; 1996 Apr; 9(4):333-44. PubMed ID: 8738209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutating three residues in the bovine rod cyclic nucleotide-activated channel can switch a nucleotide from inactive to active.
    Scott SP; Cummings J; Joe JC; Tanaka JC
    Biophys J; 2000 May; 78(5):2321-33. PubMed ID: 10777730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allosteric activation and tuning of ligand efficacy in cyclic-nucleotide-gated channels.
    Tibbs GR; Goulding EH; Siegelbaum SA
    Nature; 1997 Apr; 386(6625):612-5. PubMed ID: 9121585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular interactions of 3',5'-cyclic purine analogues with the binding site of retinal rod ion channels.
    Scott SP; Tanaka JC
    Biochemistry; 1995 Feb; 34(7):2338-47. PubMed ID: 7532007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular mechanism of cyclic-nucleotide-gated channel activation.
    Goulding EH; Tibbs GR; Siegelbaum SA
    Nature; 1994 Nov; 372(6504):369-74. PubMed ID: 7969497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three residues predicted by molecular modeling to interact with the purine moiety alter ligand binding and channel gating in cyclic nucleotide-gated channels.
    Scott SP; Tanaka JC
    Biochemistry; 1998 Dec; 37(49):17239-52. PubMed ID: 9860838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Control of ligand specificity in cyclic nucleotide-gated channels from rod photoreceptors and olfactory epithelium.
    Altenhofen W; Ludwig J; Eismann E; Kraus W; Bönigk W; Kaupp UB
    Proc Natl Acad Sci U S A; 1991 Nov; 88(21):9868-72. PubMed ID: 1719541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A functioning chimera of the cyclic nucleotide-binding domain from the bovine retinal rod ion channel and the DNA-binding domain from catabolite gene-activating protein.
    Scott SP; Weber IT; Harrison RW; Carey J; Tanaka JC
    Biochemistry; 2001 Jun; 40(25):7464-73. PubMed ID: 11412099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mechanism for ligand discrimination of cyclic nucleotide-gated channels.
    Varnum MD; Black KD; Zagotta WN
    Neuron; 1995 Sep; 15(3):619-25. PubMed ID: 7546741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct structural determinants of efficacy and sensitivity in the ligand-binding domain of cyclic nucleotide-gated channels.
    Young EC; Krougliak N
    J Biol Chem; 2004 Jan; 279(5):3553-62. PubMed ID: 14594805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A state-independent interaction between ligand and a conserved arginine residue in cyclic nucleotide-gated channels reveals a functional polarity of the cyclic nucleotide binding site.
    Tibbs GR; Liu DT; Leypold BG; Siegelbaum SA
    J Biol Chem; 1998 Feb; 273(8):4497-505. PubMed ID: 9468504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural basis for ligand selectivity of heteromeric olfactory cyclic nucleotide-gated channels.
    Shapiro MS; Zagotta WN
    Biophys J; 2000 May; 78(5):2307-20. PubMed ID: 10777729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequence of events underlying the allosteric transition of rod cyclic nucleotide-gated channels.
    Sunderman ER; Zagotta WN
    J Gen Physiol; 1999 May; 113(5):621-40. PubMed ID: 10228179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Probing the interactions between cAMP and cGMP in cyclic nucleotide-gated channels using covalently tethered ligands.
    He Y; Karpen JW
    Biochemistry; 2001 Jan; 40(1):286-95. PubMed ID: 11141082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional roles of aromatic residues in the ligand-binding domain of cyclic nucleotide-gated channels.
    Li J; Lester HA
    Mol Pharmacol; 1999 May; 55(5):873-82. PubMed ID: 10220566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of allosteric modulation of rod cyclic nucleotide-gated channels.
    Sunderman ER; Zagotta WN
    J Gen Physiol; 1999 May; 113(5):601-20. PubMed ID: 10228178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presynaptic cyclic nucleotide-gated ion channels modulate neurotransmission in the mammalian olfactory bulb.
    Murphy GJ; Isaacson JS
    Neuron; 2003 Feb; 37(4):639-47. PubMed ID: 12597861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction between prostaglandin E2 and l-cis-diltiazem, a specific blocker of cyclic nucleotide gated channels in bovine aortic endothelial cells.
    Shalom R; Barki-Harrington L; Rimon G
    Eur J Pharmacol; 2006 Aug; 543(1-3):8-13. PubMed ID: 16842773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A point mutation in the pore region alters gating, Ca(2+) blockage, and permeation of olfactory cyclic nucleotide-gated channels.
    Gavazzo P; Picco C; Eismann E; Kaupp UB; Menini A
    J Gen Physiol; 2000 Sep; 116(3):311-26. PubMed ID: 10962010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single cyclic nucleotide-gated channels locked in different ligand-bound states.
    Ruiz ML; Karpen JW
    Nature; 1997 Sep; 389(6649):389-92. PubMed ID: 9311781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.